EJF Capital LP: AMTB position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EJF Capital LP on AMTB, newest first. How the timeline and the estimate are built.
EJF Capital LP held 0 AMTB shares at 2025-12-31 per its 13F-HR filed 2026-02-17.
the latest 13F is the newest step
- period ended2025-12-3113F 0 sharesChange vs previous 13F -26,031 shares
13F-HR 0000895345-26-000034 filed by EJF Capital LP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
Exited: the 13F for this period no longer lists the position.
- period ended2025-09-3013F 26,031 sharesChange vs previous 13F +873 shares
0.29% of the 13F portfolio, value $501,617.
13F-HR 0000895345-25-000350 filed by EJF Capital LP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 25,158 sharesChange vs previous 13F -98,839 shares
0.36% of the 13F portfolio, value $458,630.
13F-HR 0000895345-25-000264 filed by EJF Capital LP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 123,997 sharesChange vs previous 13F +10,051 shares
1.62% of the 13F portfolio, value $2,559,298.
13F-HR 0000895345-25-000172 filed by EJF Capital LP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-12-3113F 113,946 sharesChange vs previous 13F +13,946 shares
1.75% of the 13F portfolio, value $2,553,530.
13F-HR 0000895345-25-000054 filed by EJF Capital LP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-09-3013F 100,000 sharesChange vs previous 13F not available
1.42% of the 13F portfolio, value $2,137,000.
13F-HR 0000895345-24-000584 filed by EJF Capital LP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).